Read article Announcement
Cancer Research UK participates in ICGC
Thursday 14 July 2011
Cancer Research UK is participating in the International Cancer Genome Consortium (ICGC), helping to build the largest ever map of the genomic changes that drive 50 different tumour and/or subtypes types.
ICGC will produce vast amounts of genetic information, and this 'blueprint for cancer' will fuel the search for better, more personalised treatments for the millions of people worldwide who are diagnosed with the disease every year.
Cancer Research UK is leading on a project to map the faults in oesophageal cancer, and jointly leading on a prostate cancer project with the Ontario Institute of Cancer Research and Prostate Cancer Canada.
Understanding the genetic faults that drive these cancers will give clues for new, more targeted ways to treat patients and save more lives.
See Strategic initiatives for more information about Cancer Research UK's involvement in ICGC. Alternatively, read our Science Update Blog for the plain English version.
Recent announcements, news and press releases
- News story: World leaders must 'take tobacco much more seriously' to achieve development goals (12 Feb 2013)
- Press Release: MPs sent cigarette packs to highlight their deadly design (12 Feb 2013)
- Press Release: Late diagnosis and lack of treatment access may contribute to poor UK lung cancer survival (11 Feb 2013)
- News story: Genetically engineered virus extends the lives of terminally-ill liver cancer patients (11 Feb 2013)
- Press Release: Early results show two drugs may be better than one to treat most deadly skin cancer (11 Feb 2013)
Increase text size
Decrease text size
Print page